Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
10.1126/scitranslmed.3007653 Sci
Recent studies show a clear gap between clinical trial results and real-world outcomes for GLP-1 agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
Don't spend another month wishing for change
Typically, the High Option plan has a more generous drug formulary and lower out-of-pocket costs than the Standard Option plan, but it also comes with a higher monthly premium
PMID 10652368
It tends to suit readers who want convenient virtual access to a GLP-1 prescription with clinical oversight and ongoing follow-up, and who are comfortable with a cash-pay model
US$ 28.36
US$ 21.45
US$ 22.64
US$ 20.56
US$ 19.99
